1. EachPod
EachPod

Episode 2: A Novel Treatment for Beta-Mannosidosis

Author
Erin Hubbard
Published
Fri 28 Feb 2025
Episode Link
https://rss.com/podcasts/these-kids-cant-wait/1918310

πŸŽ™οΈ Hosts: Lorena Lomelin and Phoebe Wang

🎀 Guest: Dr. Virginia Kimonis

πŸ“… Release Date:2/28/2025

πŸ”¬ Topic: A deep dive into rare disease research.

Episode Summary:

In this episode of These Kids Can’t Wait, hosts Lorena Lomelin and Phoebe Wang sits down with Dr. Virginia Kimonis, a nationally renowned expert in genetics and clinical biochemical genetics, to discuss her groundbreaking work on Beta-Mannosidosis and the development of a novel treatment. Dr. Kimonis shares her journey into rare disease research, the challenges of treating lysosomal storage disorders, and the innovative science behind The Lost Enzyme Project. We also explore the impact of this research on patients and families, the funding challenges in rare disease research, and the future of treatments for ultra-rare conditions.

Key Takeaways:

βœ”οΈ What lysosomal storage disorders are and why they’re challenging to treat

βœ”οΈ An overview of Beta-Mannosidosis, its symptoms and the challenges faced

βœ”οΈ The process of developing a treatment, from preclinical research to clinical trials

βœ”οΈ The future of rare disease research and the potential for gene therapy

Resources & Links

🌐 Learn more: https://thelostenzymeproject.org/ or https://bit.ly/lostenzyme

πŸ“’ Follow us on social media: https://www.linkedin.com/feed/

https://www.instagram.com/thelostenzymeproject/

https://www.facebook.com/people/The-Lost-Enzyme-Project/61551541563692/

πŸ“© Contact us: Email us at [email protected] to get in contact with our producer at [email protected]

Dr. Kimonis’s lab: https://www.mammag.uci.edu/kimonis/index.asp

Subscribe & Stay Connected

Stay informed by subscribing to These Kids Can’t Wait on [Spotify, Apple Podcasts, or preferred platform]. If you find this episode valuable, please leave a review to help raise awareness for rare disease research.

Share to: